Introducción Impulsada por cambios en prácticas sociales y comportamentales, la epidemiología del cáncer gastroesofágico en EE. UU. experimentó una evolución

Treatment advances in esophageal cancer have improved survival and other outcomes but have also raised new questions about how to

Introduction The FDA has recently granted accelerated approval for camizestrant (Etcamah), a novel oral selective estrogen receptor degrader (SERD), specifically